Innovation is the lifeblood of any organisation. Over the coming years of economic uncertainty and the increasing burden of cardiovascular disease, there has never been a more pressing demand for healthcare innovation.
Our Cardiovascular Innovations division develops partnerships with industry to facilitate clinical research trials, translational research and technology adoption. We launched this division in 2013 and now provide services to a range of global pharmaceutical companies, cardiovascular research departments at leading Universities and the medical devices industry. Our service focuses on medicines, devices and techniques that seamlessly integrate into front-line service delivery, leading to efficiency gains and enhanced outcomes for patients.
For any new enquiry, please contact us via this email: innovations@regentsparkhealthcare.com